Coenzyme Q10 supplementation and oxidative stress parameters: a systematic review and meta-analysis of clinical trials Abolfazl AkbariGholam Reza MobiniSadegh Dehghani Review 25 June 2020 Pages: 1483 - 1499
What about COVID-19 and arachidonic acid pathway? Malvina Hoxha Special Article 25 June 2020 Pages: 1501 - 1504
Pharmacokinetics and pharmacodynamics of intranasal remimazolam—a randomized controlled clinical trial Marija PesicFrank SchippersThomas Stoehr Pharmacodynamics Open access 04 September 2020 Pages: 1505 - 1516
Body weight, CYP2C19, and P2Y12 receptor polymorphisms relate to clopidogrel resistance in a cohort of Chinese ischemic stroke patients with aspirin intolerance Zhiqiang LiWanqing DongYan Wang Pharmacogenetics 06 July 2020 Pages: 1517 - 1527
Novel method to estimate the appropriate dosing interval for activated charcoal to avoid interaction with other drugs Hisakazu OhtaniKota NakamuraTakeshi Akiyoshi Pharmacokinetics and Disposition 17 June 2020 Pages: 1529 - 1536
Correction to: Novel method to estimate the appropriate dosing interval for activated charcoal to avoid interaction with other drugs Hisakazu OhtaniKota NakamuraTakeshi Akiyoshi Correction 16 September 2020 Pages: 1537 - 1537
Population pharmacokinetic analysis of bisoprolol in type 2 diabetic patients with hypertension Stefan MomčilovićAndriana JovanovićJasmina R. Milovanović Pharmacokinetics and Disposition 25 June 2020 Pages: 1539 - 1546
Population pharmacokinetics and dose optimization of ceftriaxone for children with community-acquired pneumonia Muhammad Wasim KhanYa-Kun WangWei Zhao Pharmacokinetics and Disposition 25 June 2020 Pages: 1547 - 1556
Probability of mycobactericidal activity of para-aminosalicylic acid with novel dosing regimens Ahmed A. AbulfathiPiyanan AssawasuwannakitElin M. Svensson Pharmacokinetics and Disposition 25 June 2020 Pages: 1557 - 1565
A survey about label enhancement methods for parenteral medication in European hospital pharmacies K. H. M. Larmené-BeldR. N. KeersK. Taxis Pharmacoepidemiology and Prescription Open access 20 June 2020 Pages: 1567 - 1571
Better survival in impaired renal function patients with metastatic non-small cell lung cancer treated by cisplatin-pemetrexed Louis MagaliFoucher PascalMousson Christiane Pharmacoepidemiology and Prescription 21 June 2020 Pages: 1573 - 1580
Optimizing the MIC breakpoints of amoxicillin and tetracycline for antibiotic selection in the rescue therapy of H. pylori with bismuth quadruple regimen Ming-Tsung HsiehWei-Lun ChangBor-Shyang Sheu Pharmacoepidemiology and Prescription 27 June 2020 Pages: 1581 - 1589
Adverse drug reactions in infants, children and adolescents exposed to antidepressants: a French pharmacovigilance study Simon BarthezAlexis RevetFrançois Montastruc Pharmacoepidemiology and Prescription 25 June 2020 Pages: 1591 - 1599
Adverse drug reactions to anti-diabetic drugs are commonest in patients whose treatment do not adhere to diabetes management clinical guidelines: cross-sectional study in a tertiary care service in sub-Saharan Africa Agnes ElangweJean-Claude KatteJean Claude Mbanya Pharmacoepidemiology and Prescription 30 June 2020 Pages: 1601 - 1605
Validation of self-reported adherence in chronic patients visiting pharmacies and factors associated with the overestimation and underestimation of good adherence C. Valdés y LlorcaErnesto Cortés-CastellM. Rizo-Baeza Pharmacoepidemiology and Prescription 01 July 2020 Pages: 1607 - 1614
The added value of pirfenidone to fight inflammation and fibrotic state induced by SARS-CoV-2 Francesco FerraraGiovanni GranataAntonio Vitiello Point of View 27 June 2020 Pages: 1615 - 1618
Can iron chelation as an adjunct treatment of COVID-19 improve the clinical outcome? Anis Abobaker Letter to the Editor 30 June 2020 Pages: 1619 - 1620
Serotonin transporter gene and escitalopram: depressing medical science Alain Braillon Letter to the Editor 26 June 2020 Pages: 1621 - 1622
